Home Newsfeeds JP Morgan Downgrades Nu Holdings to Underweight

JP Morgan Downgrades Nu Holdings to Underweight

JP Morgan analyst Domingos Falavina downgrades Nu Holdings (NYSE:NU) from Neutral to Underweight.

byBenzinga Newsdesk

November 11, 2022

1 minute read

JP Morgan analyst Domingos Falavina downgrades Nu Holdings (NYSE:NU) from Neutral to Underweight.

Meet Entrepreneur, Crypto Expert Carlos Vivas At Benzinga’s Future Of Digital Assets Event

By Murtuza Merchant

October 18, 9:30 AM

Carlos Vivas, director and senior principal engineer at The Depository Trust & Clearing Corporation (DTCC), is recognized for his contributions to the world of technology and finance.

ETH

Sensei Biotherapeutics Reports Clinical Data For SNS-101 At 2023 SITC Annual Meeting

By Benzinga Newsdesk

November 3, 4:06 PM

- Clinical dose escalation data for SNS-101 monotherapy show well tolerated safety profile, potentially best-in-class pharmacokinetics, and encouraging cytokine release profile across multiple dose cohorts - - First

SNSE

Why c3.ai Stock Is Shooting Higher In Thursday’s Premarket

By Shanthi Rexaline

May 25, 7:46 AM

The optimism relayed by Nvidia Corp.’s (NASDAQ:NVDA) first-quarter results have proved to be contagious, as it has set…

Frontline Q4 EPS $0.97 Misses $1.06 Estimate, Sales $530.10M Beat $365.02M Estimate

By Benzinga Newsdesk

February 28, 6:49 AM

Frontline (NYSE:FRO) reported quarterly earnings of $0.97 per share which missed the analyst consensus estimate of $1.06 by 8.49 percent. This is a 4950 percent increase over losses of $(0.02) per share from the same

FRO

JP Morgan Downgrades Nu Holdings to Underweight

Related Posts

Meet Entrepreneur, Crypto Expert Carlos Vivas At Benzinga’s Future Of Digital Assets Event

Sensei Biotherapeutics Reports Clinical Data For SNS-101 At 2023 SITC Annual Meeting

Why c3.ai Stock Is Shooting Higher In Thursday’s Premarket

Frontline Q4 EPS $0.97 Misses $1.06 Estimate, Sales $530.10M Beat $365.02M Estimate